Correlation of induction of ATP binding cassette transporter A5 (ABCA5) and ABCB1 mRNAs with differentiation state of human colon tumor

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 6, 2007, Pages 1144-1146

  Ohtsuki, Sumio ^a,b   Kamoi, Mayu ^a   Watanabe, Yuki ^a   Suzuki, Hiroya ^a   Hori, Satoko ^a,b   Terasaki, Tetsuya ^a,b  

^a TOHOKU UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

ABC transporter A5 (ABCA5); ATP binding cassette (ABC) transporter; Colon adenocarcinoma; mRNA expression; Tumor

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A10; ABC TRANSPORTER A2; ABC TRANSPORTER A5; ABC TRANSPORTER A6; ABC TRANSPORTER A7; ABC TRANSPORTER A8; ABC TRANSPORTER C1; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; UNCLASSIFIED DRUG;

ARTICLE; BRAIN; CELL DIFFERENTIATION; COLON ADENOCARCINOMA; COLON CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE INDUCTION; HUMAN; HUMAN TISSUE; LIVER; LUNG; NUCLEOTIDE SEQUENCE; OVARY CARCINOMA; TISSUE DISTRIBUTION;

ADENOCARCINOMA; ATP-BINDING CASSETTE TRANSPORTERS; COLONIC NEOPLASMS; DNA, COMPLEMENTARY; FEMALE; HUMANS; MALE; ORGANIC ANION TRANSPORTERS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE DISTRIBUTION;

EID: 34249996281     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.1144     Document Type: Article

References (15)

1. Sarkadi B., Homolya L., Szakacs G., Varadi A., Physiol. Rev., 86, 1179-1236 (2006).
2. Takahashi K., Kimura Y., Nagata K., Yamamoto A., Matsuo M., Ueda K., Med. Mol. Morphol., 38, 2-12 (2005).
3. Annilo T., Chen Z. Q., Shulenin S., Dean M., Mamm. Genome, 14, 7-20 (2003).
4. Tsuruoka S., Ishibashi K., Yamamoto H., Wakaumi M., Suzuki M., Schwartz G. J., Imai M., Biochem. Biophys. Res. Commun., 298, 41-45 (2002).
5. Kubo Y., Sekiya S., Ohigashi M., Takenaka C., Tamura K., Nada S., Nishi T., Yamamoto A.,Yamaguchi A., Mol. Cell. Biol., 25, 4138-4149 (2005).
6. Petry F., Ritz V., Meineke C., Middel P., Kietzmann T., Schmitz-Salue C., Hirsch-Ernst K. I., Biochem. J., 393, 79-87 (2006).
7. Hurst J., Maniar N., Tombarkiewicz J., Lucas F., Roberson C., Steplewski Z., James W., Perras J., Br. J. Cancer, 68, 274-276 (1993).
8. Anderson W. K., Cancer Res., 42, 2168-2170 (1982).
9. Schmid F. A., Sirotnak F. M., Otter G. M., DeGraw J. I., Cancer Treat. Rep., 69, 551-553 (1985).
10. Ni X., Gu S., Dai J., Cheng H., Guo L., Li L., Ji C., Xie Y., Ying K., Mao Y., J. Hum. Genet., 48, 96-100 (2003).
11. Kaighn M. E., Narayan K. S., Ohnuki Y., Lechner J. F., Jones L. W., Invest. Urol., 17, 16-23 (1979).
12. Boonstra R., Timmer-Bosscha H., van Echten-Arends J., van der Kolk D. M., van den Berg A., de Jong B., Tew K. D., Poppema S., de Vries E. G., Br. J. Cancer, 90, 2411-2417 (2004).
13. Kramer R., Weber T. K., Arceci R., Morse B., Simpson H., Steele G. D., Jr., Summerhayes I. C., Int. J. Cancer, 54, 275-281 (1993).
14. Iishi H., Tatsuta M., Baba M., Okuda S., Taniguchi H., Int. J. Cancer, 50, 974-976 (1992).
15. Mitin T., Von Moltke L. L., Court M. H., Greenblatt D. J., Drug Metab. Dispos., 32, 779-782 (2004).